Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Market Cap: 212.50M for May 24, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 23, 2024 | 224.23M |
May 22, 2024 | 212.50M |
May 21, 2024 | 217.28M |
May 20, 2024 | 207.72M |
May 17, 2024 | 205.11M |
May 16, 2024 | 212.06M |
May 15, 2024 | 210.76M |
May 14, 2024 | 214.24M |
May 13, 2024 | 193.81M |
May 10, 2024 | 219.45M |
May 09, 2024 | 242.05M |
May 08, 2024 | 238.14M |
May 07, 2024 | 248.56M |
May 06, 2024 | 259.86M |
May 03, 2024 | 263.77M |
May 02, 2024 | 264.21M |
May 01, 2024 | 261.60M |
April 30, 2024 | 271.16M |
April 29, 2024 | 289.41M |
April 26, 2024 | 292.60M |
April 25, 2024 | 269.19M |
April 24, 2024 | 276.99M |
April 23, 2024 | 279.16M |
April 22, 2024 | 263.99M |
April 19, 2024 | 255.75M |
Date | Value |
---|---|
April 18, 2024 | 254.45M |
April 17, 2024 | 253.15M |
April 16, 2024 | 243.18M |
April 15, 2024 | 237.98M |
April 12, 2024 | 203.30M |
April 11, 2024 | 219.77M |
April 10, 2024 | 229.31M |
April 09, 2024 | 231.91M |
April 08, 2024 | 233.21M |
April 05, 2024 | 256.62M |
April 04, 2024 | 260.08M |
April 03, 2024 | 260.95M |
April 02, 2024 | 262.69M |
April 01, 2024 | 276.56M |
March 28, 2024 | 276.94M |
March 27, 2024 | 271.38M |
March 26, 2024 | 258.13M |
March 25, 2024 | 256.85M |
March 22, 2024 | 259.84M |
March 21, 2024 | 250.01M |
March 20, 2024 | 261.12M |
March 19, 2024 | 253.86M |
March 18, 2024 | 257.28M |
March 15, 2024 | 262.41M |
March 14, 2024 | 261.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
CEL-SCI Corp | 67.16M |
AIM ImmunoTech Inc | 19.74M |
IGC Pharma Inc | 30.73M |
NovaBay Pharmaceuticals Inc | 4.986M |
Protalix BioTherapeutics Inc | 90.18M |
Market Cap Related Metrics
PS Ratio | 11.26 |
Price to Book Value | 1.807 |
Price | 4.89 |
Earnings Yield | -22.29% |